Carbidopa attenuation of L-DOPA emesis in dogs: evidence for a cerebral site of action outside the blood-brain barrier.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001665:Binding Sites / Q000187:drug effects; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D002230:Carbidopa / Q000494:pharmacology; D002552:Cerebral Ventricles; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004285:Dogs; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology; D004639:Emetics / Q000037:antagonists & inhibitors*; D006834:Hydrazines / Q000494:pharmacology*; D007267:Injections; D007275:Injections, Intravenous
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004639:Emetics; D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D002230:Carbidopa; D004298:Dopamine